Logo image of LXEH

LIXIANG EDUCATION HOLDIN-ADR (LXEH) Stock Analyst Earnings Estimates

NASDAQ:LXEH - Nasdaq - US53934A2069 - ADR - Currency: USD

2.1  -0.78 (-27.08%)

After market: 2.15 +0.05 (+2.38%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
LXEH revenue by date.LXEH revenue by date.
49.182M
42.82%
51M
3.70%
33M
-35.29%
EBITDA
YoY % growth
LXEH ebitda by date.LXEH ebitda by date.
-17.62M
-687.53%
-79.87M
-353.29%
-21.4M
73.21%
EBIT
YoY % growth
LXEH ebit by date.LXEH ebit by date.
-24.572M
-1,801.86%
-86M
-249.99%
-26M
69.77%
Operating Margin
LXEH operating margin by date.LXEH operating margin by date.
-49.96%-168.63%-78.79%
EPS
YoY % growth
LXEH eps by date.LXEH eps by date.
N/AN/AN/A

All data in CNY

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CNY

Recent Earnings VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (CNY)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
17M
-32.00%
%
Q2 2024
Q2Q % growth
15M
-42.31%
%
Q4 2023
Q2Q % growth
25M
-5.41%
%
Q2 2023
Q2Q % growth
26M
14.28%
%
Q4 2022
Q2Q % growth
26.43M
131.60%
%
Q2 2022
Q2Q % growth
22.752M
-1.18%
%
Q4 2021
Q2Q % growth
11.412M
-55.60%
%
Q2 2021
Q2Q % growth
23.024M
-73.46%
%
Q4 2020
Q2Q % growth
25.705M
91.37%
%
Q2 2020
Q2Q % growth
86.741M
3.10%
%
LXEH Yearly Revenue VS EstimatesLXEH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 50M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A